Drug Trial Radar · NCT07553663
Evaluating the Pharmacokinetics and Safety of Miricorilant
Last checked: Nov 20, 2026Latest source record: Oct 16, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
14
Actual
Start
Apr 30, 2026
Primary completion
Sep 22, 2026
Study completion Sep 22, 2026
Sponsor
- Lead sponsor
- Corcept TherapeuticsIndustry
- Sponsor type
- Industry
- First posted
- Apr 28, 2026
Design
- Study type
- Interventional
- Phase
- Phase 1
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
A Phase 1b, Open-Label Study Evaluating the Pharmacokinetics and Safety of Miricorilant in Adult Patients With Presumed Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Conditions
- Nonalcoholic Steatohepatitis (NASH)
- Metabolic Dysfunction-Associated Steatohepatitis (MASH) / Nonalcoholic Steatohepatitis (NASH) With Compensated Cirrhosis
- Metabolic Dysfunction-associated Steatotic Liver Disease (MASLD)
- Non-alcoholic Fatty Liver Disease (NAFLD)
Interventions
MiricorilantDrug
Single dose of 60 mg miricorilant
Primary outcomes
What the sponsor says the trial is designed to measure.
- Assessment of miricorilant PK parametersTime frame: Day 1- Day 4
- Assessment of miricorilant PK parametersTime frame: Day 1 - Day 4
- Assessment of miricorilant PK parametersTime frame: Day 1 - Day 4
- Assessment of miricorilant PK parametersTime frame: Day 1 - Day 4
- Assessment of miricorilant PK parametersTime frame: Day 1 - Day 4
- Assessment of miricorilant PK parametersTime frame: Day 1 - Day 4
- Assessment of miricorilant PK parametersTime frame: Day 1 - Day 4
- Assessment of miricorilant PK parametersTime frame: Day 1 - Day 4
Locations
1 site in 1 country. Site status is shown where the registry gives one.
Site# 433
San Antonio, Texas
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.